Similar to the changes in Ki67+ proliferating cells, the growth-inhibitory effect of ACR on EpCAM+ cells was significantly reduced in TG2 knockdown HCC cells, suggesting that TG2 is a target of ACR in liver CSCs. This evidence concerns the gene EPCAM and hepatocellular carcinoma.